Daxor CorporationDXRNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
5Y CAGR+97.1%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

5Y CAGR
+97.1%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
29.7x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
20251824.65%+1789.1%
202496.59%+10032.4%
20230.95%+100.1%
2022-1729.22%-852.4%
2021-181.56%-395.8%
202061.37%-85.8%
2019431.07%+225.0%
2018132.65%+10.4%
2017120.14%+78.0%
201667.49%-